Reversible parkinsonian syndrome in systemic and brain vasculitis.
A young female patient with chronic renal failure due to a systemic vasculitis and a parkinsonian syndrome secondary to brain vasculitis, most likely systemic lupus erythematosus, is described. The patient had a dramatic response to a pulse of methylprednisolone, with remission of her parkinsonian symptoms.
Fabiani
Giorgio
G
Movement Disorder Unit - Service of Neurology, Hospital de Clínicas, Federal University of Paraná, Curitiba, PR, Brazil. giorgiof@osite.com.br
Teive
Hélio A G
HA
Germiniani
Francisco M B
FM
Sá
Daniel S
DS
Werneck
Lineu César
LC
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D020945:Lupus Vasculitis, Central Nervous System / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D020734:Parkinsonian Disorders / Q000209:etiology*; D020551:Pulse Therapy, Drug; D015899:Tomography, Emission-Computed, Single-Photon; D016896:Treatment Outcome; D014657:Vasculitis / Q000175:diagnosis / Q000209:etiology*
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone